Insulin Aspart (Vials) (Fiasp) and Mogamulizumab
Determining the interaction of Insulin Aspart (Vials) (Fiasp) and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart (Vials) (Fiasp)-Mogamulizumab-kpkc
- Insulin Aspart (Vials) (Fiasp)-Mogamulizumab-kpkc Intravenous
- Insulin Aspart (Vials) (Fiasp)-Molindone
- Insulin Aspart (Vials) (Fiasp)-Mometasone (Oral Inhalation)
- Insulin Aspart (Vials) (Fiasp)-Mometasone and Formoterol
- Insulin Aspart (Vials) (Fiasp)-Mometasone and formoterol Inhalation
- Mogamulizumab-Insulin aspart and insulin aspart protamine
- Mogamulizumab-Insulin aspart and insulin degludec Subcutaneous
- Mogamulizumab-Insulin Aspart Injection
- Mogamulizumab-Insulin Aspart Protamine and Insulin Aspart
- Mogamulizumab-Insulin aspart protamine and insulin aspart Subcutaneous
- Mogamulizumab-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)